Molecular formula: | C28H32N4O3 |
Average mass: | 472.589 |
Monoisotopic mass: | 472.247441 |
ChemSpider ID: | 28518965 |
Double-bond stereo
Wikipedia
((2E,16E)-11-[2-(pirrolidin-1-il)etoxi]-14,19-dioxa- 5,7,27-triazatetraciclo[19.3.1.12,6.18,12]heptacosa1(25),2,4,6,8,10,12(26),16,21,23-decaeno
[Spanish]
((2E,16E)-11-[2-(pyrrolidin-1-yl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6,8,10,12(26),16,21,23-decaene
(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1~2,6~.1~8,12~]heptacosa-1(25),2(27),3,5,8(26),9,11,16,21,23-decaen
[German]
[ACD/IUPAC Name](16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1~2,6~.1~8,12~]heptacosa-1(25),2(27),3,5,8(26),9,11,16,21,23-decaene
[ACD/IUPAC Name](16E)-11-[2-(1-Pyrrolidinyl)éthoxy]-14,19-dioxa-5,7,27-triazatétracyclo[19.3.1.1~2,6~.1~8,12~]heptacosa-1(25),2(27),3,5,8(26),9,11,16,21,23-décaène
[French]
[ACD/IUPAC Name](16E)-11-[2-(pyrrolidin-1-yl)éthoxy]-14,19-dioxa-5,7,27-triazatétracyclo[19.3.1.12,6.18,12]heptacosa-1(24),2,4,6,8,10,12(26),16,21(25),22-décaène
[French]
14,19-Dioxa-5,7,27-triazatetracyclo[19.3.1.1~2,6~.1~8,12~]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 11-[2-(1-pyrrolidinyl)ethoxy]-, (16E)-
[ACD/Index Name]937272-79-2
[RN]G22N65IL3O
[UNII]pacritinib
[Spanish]
[INN]pacritinib
[French]
[INN]pacritinibum
[Latin]
Vonjo
[Trade name]11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
11-[2-(1-pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16E,21,23-decaene
FLT3_HUMAN
JAK1_HUMAN
JAK2_HUMAN
JAK3_HUMAN
MFCD22572772
[MDL number]ONX-0803::Pacritinib::SB-1518::SB1518
pacritinibum
TYK2_HUMAN
Tyrosine-protein kinase JAK1
Tyrosine-protein kinase JAK2
Tyrosine-protein kinase JAK3
пакритиниб
[Russian]باكريتينيب
[Arabic]帕瑞替尼
[Chinese]